"My conclusions from the available trial data (as per the publications and FDA submissions documents) are the following:
- The observed reductions in test-positivity for the SARS-CoV-2 virus (the “95 percent efficacy”) in people presenting with a common cold or flu are an interesting biological result – if they are real (The numbers are small, and clinical reality appears to not confirm this result).
- Clinically, people were much sicker (altogether more common cold and flu symptoms) in the vaccine than in the placebo groups.
- No conclusions can be drawn for severe forms of pneumonia and mortality.
- As Covid-19 is a disease with non-specific symptoms, the pivotal trial endpoint would have to be all-cause pneumonias and all-cause mortality, in order to gauge any intervention’s clinical benefit (or harm).
Any public health model needs good and credible clinical and epidemiological data for its input and algorithms. For the Covid-19 vaccines, good and credible data demonstrating a prevention of severe pneumonia, hospitalization, and death do not exist. My conclusion from the clinic and the epidemiology is that they cannot exist.
It is therefore not surprising that published models yield absurd results. Unfortunately, it is no longer surprising either that these absurd results are being swallowed and regurgitated by medical journals and the media, by politicians and agencies.
It may be a long struggle, but the scientific truth will prevail in the end."
